News & Media

Recent News

Press Releases

Sorry, we couldn't find any posts. Please try a different search.


PharmaShots Interview: SalioGen Therapeutics’ Ray Tabibiazar Shares Insights on Gene Coding Platform

VCs plow $115M into next-gen genetic medicine startup SalioGen, teeing up work on eye and liver diseases

Gene therapy 3.0 efforts net SalioGen a nine-figure Series B, but much remains under wraps

Gene-coding startup brings in $115M, eyes expansion (Subscription Required)

The renowned drug hunter, the Washington insider, the MIT strategist: How did one low-profile biotech enlist a dream team of top biotech advisors?  (Subscription Required)

Looking to take advantage of ‘silenced’ enzymes, SalioGen emerges from stealth with eyes set on gene therapy 3.0